Net profit of Godavari Drugs declined 1.55% to Rs 1.27 crore in the quarter ended March 2022 as against Rs 1.29 crore during the previous quarter ended March 2021. Sales rose 34.34% to Rs 44.28 crore in the quarter ended March 2022 as against Rs 32.96 crore during the previous quarter ended March 2021.
For the full year,net profit rose 27.12% to Rs 5.25 crore in the year ended March 2022 as against Rs 4.13 crore during the previous year ended March 2021. Sales rose 31.34% to Rs 161.11 crore in the year ended March 2022 as against Rs 122.67 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 44.28 | 32.96 | 34 | 161.11 | 122.67 | 31 |
OPM % | 6.12 | 7.80 | – | 7.01 | 8.01 | – |
PBDT | 2.21 | 1.87 | 18 | 8.73 | 6.93 | 26 |
PBT | 1.79 | 1.50 | 19 | 7.03 | 5.71 | 23 |
NP | 1.27 | 1.29 | -2 | 5.25 | 4.13 | 27 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.